This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Wafik El-Deiry, a Brown University cancer researcher and pandemic-era free speech advocate, is calling for a budget for the ...

Summit Therapeutics stock plunged Friday after its highly watched cancer drug failed to significantly improve overall survival.

Keros will be down to 85 full-time employees after the layoffs and expects to generate annualized savings of $17 million.

Less than a year after garnering the first anti-CLDN18.2 approval in the U.S., Astellas Pharma is not resting on its laurels.

In 2025, the global proteose peptone market is anticipated to be worth USD 151.4 million, with projections indicating a rise ...

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

While India grapples with rising Covid cases and prepares for potential biological threats, the government's neglect of its ...

The startup is the latest beneficiary of investors’ appetite for protein-degrading technology, which offers a way to reach ...

BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...